Correlation Between Microsoft and POINT Biopharma
Can any of the company-specific risk be diversified away by investing in both Microsoft and POINT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and POINT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and POINT Biopharma Global, you can compare the effects of market volatilities on Microsoft and POINT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of POINT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and POINT Biopharma.
Diversification Opportunities for Microsoft and POINT Biopharma
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Microsoft and POINT is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and POINT Biopharma Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on POINT Biopharma Global and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with POINT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of POINT Biopharma Global has no effect on the direction of Microsoft i.e., Microsoft and POINT Biopharma go up and down completely randomly.
Pair Corralation between Microsoft and POINT Biopharma
Given the investment horizon of 90 days Microsoft is expected to generate 2.11 times less return on investment than POINT Biopharma. But when comparing it to its historical volatility, Microsoft is 2.07 times less risky than POINT Biopharma. It trades about 0.08 of its potential returns per unit of risk. POINT Biopharma Global is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 661.00 in POINT Biopharma Global on September 2, 2024 and sell it today you would earn a total of 245.00 from holding POINT Biopharma Global or generate 37.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 31.05% |
| Values | Daily Returns |
Microsoft vs. POINT Biopharma Global
Performance |
| Timeline |
| Microsoft |
| POINT Biopharma Global |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Microsoft and POINT Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and POINT Biopharma
The main advantage of trading using opposite Microsoft and POINT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, POINT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in POINT Biopharma will offset losses from the drop in POINT Biopharma's long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Block Inc | Microsoft vs. Adobe Systems Incorporated |
| POINT Biopharma vs. Oric Pharmaceuticals | POINT Biopharma vs. Lyra Therapeutics | POINT Biopharma vs. Inhibrx | POINT Biopharma vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |